General Information of the Compound
| Compound ID |
CP0416118
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S)-1-[2-(3,4-dimethoxyanilino)pyrimidin-4-yl]-N-[(4-methylphenyl)methyl]piperidine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H31N5O3
|
||||||||||||||||||
| Molecular Weight |
461.566
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(Nc2nccc(n2)N2CCC[C@@H](C2)C(=O)NCc2ccc(C)cc2)cc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H31N5O3/c1-18-6-8-19(9-7-18)16-28-25(32)20-5-4-14-31(17-20)24-12-13-27-26(30-24)29-21-10-11-22(33-2)23(15-21)34-3/h6-13,15,20H,4-5,14,16-17H2,1-3H3,(H,28,32)(H,27,29,30)/t20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CMYMJBBVHUYZQV-FQEVSTJZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01203, ALK tyrosine kinase receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor